| 9353101 |
Cyclic amine substituted heterocyclic CETP inhibitors |
John J. Acton, III, Feng Ye, Petr Vachal, Deyou Sha, James F. Dropinski +6 more |
2016-05-31 |
$68,752,000 |
| 9029377 |
Platelet-activating factor receptor antagonists |
Anthony Ogawa, Feroze Ujjainwalla, Bing Li, Lan Wei, Jinyou Xu +3 more |
2015-05-12 |
$67,061,000 |
| 8796258 |
Cyclic azabenzimidazole derivatives useful as anti-diabetic agents |
Rajan Anand, James M. Apgar, Tesfaye Biftu, Ping Chen, Vincent J. Colandrea +13 more |
2014-08-05 |
$53,413,000 |
| 8729104 |
Diphenyl substituted alkanes as flap inhibitors |
Ihor E. Kopka, Bing Li, Anthony Ogawa, Feroze Ujjainwalla |
2014-05-20 |
$165,314,000 |
| 8470819 |
Benzimidazole and aza-benzimidazole carboxamides |
Anthony Ogawa, Hyun O. Ok, Feroze Ujjainwalla |
2013-06-25 |
$46,267,000 |
| 8440672 |
Diphenyl substituted alkanes |
Anthony Ogawa, Feroze Ujjainwalla, Ellen K. Vande Bunte, Debra L. Ondeyka, Ihor E. Kopka +5 more |
2013-05-14 |
$107,206,000 |
| 8426413 |
Diaryl substituted alkanes |
Bing Li, Anthony Ogawa, Hyun O. Ok, Debra L. Ondeyka, Minal Patel +3 more |
2013-04-23 |
$50,085,000 |
| 8124628 |
Diaryl substituted alkanes |
Bing Li, Anthony Ogawa, Hyun O. Ok, Debra L. Ondeyka, Minal Patel +3 more |
2012-02-28 |
$55,324,000 |
| 7629467 |
Diphenyl substituted cycloalkanes, compositions containing such compounds and methods of use |
Mark Goulet, Feroze Ujjainwalla, Linda L. Chang, Richard Frenette, Yves Girard +3 more |
2009-12-08 |
$88,079,000 |
| 6818658 |
Acylated piperidine derivatives as melanocortin-4 receptor agonists |
Feroze Ujjainwalla, Mark Goulet, Bonnie Louridas, Matthew J. Wyvratt, Daniel Warner |
2004-11-16 |
$85,612,000 |
| 6211224 |
Antagonists of gonadotropin releasing hormone |
Mark Goulet, Thomas F. Walsh, Matthew J. Wyvratt, Stephanie L. Witkin |
2001-04-03 |
$144,665,000 |
| 6200957 |
Antagonists of gonadotropin releasing hormone |
Mark Goulet, Wallace T. Ashton, Michael H. Fisher, Peter Lin, Mitree M. Ponpipom +3 more |
2001-03-13 |
$219,477,000 |
| 6197975 |
Antagonists of gonadotropin releasing hormone |
Mark Goulet, Wallace T. Ashton, Michael H. Fisher, Matthew J. Wyvratt |
2001-03-06 |
$573,385,000 |
| 6159989 |
Antagonists of gonadotropin releasing hormone |
Mark Goulet, Thomas F. Walsh, Matthew J. Wyvratt, Stephanie L. Witkin |
2000-12-12 |
$257,143,000 |
| 6156767 |
Antagonists of gonadotropin releasing hormone |
Mark Goulet, Matthew J. Wyvratt, Peter Lin, Narindar N. Girotra |
2000-12-05 |
$236,503,000 |
| 6077858 |
Antagonists of gonadotropin releasing hormone |
Mark Goulet, Feroze Ujjainwalla, Thomas F. Walsh, Matthew J. Wyvratt, Jonathan R. Young |
2000-06-20 |
$380,817,000 |
| 6017944 |
Antagonists of gonadotropin releasing hormone |
Thomas F. Walsh, Mark Goulet, Matthew J. Wyvratt, Stephanie L. Witkin |
2000-01-25 |
$177,291,000 |
| 5985901 |
Antagonists of gonadotropin releasing hormone |
Mark Goulet, Feroze Ujjainwalla, Thomas F. Walsh, Matthew J. Wyvratt, Jonathan R. Young |
1999-11-16 |
$111,398,000 |
| 5981550 |
Antagonists of gonadotropin releasing hormone |
Mark Goulet, Thomas F. Walsh, Feroze Ujjainwalla, Matthew J. Wyvratt, Jonathan R. Young |
1999-11-09 |
$104,304,000 |
| 5849764 |
Antagonists of gonadotropin releasing hormone |
Mark Goulet, Thomas F. Walsh, Michael H. Fisher, Narindar N. Girotra, Matthew J. Wyvratt +2 more |
1998-12-15 |
$77,563,000 |
| 5780437 |
Antagonists of gonadotropin releasing hormone |
Mark Goulet, Wallace T. Ashton, Michael H. Fisher, Narindar N. Girotra, Peter Lin +1 more |
1998-07-14 |
$105,697,000 |
| 5756507 |
Antagonists of gonadotropin releasing hormone |
Mark Goulet, Wallace T. Ashton, Michael H. Fisher, Matthew J. Wyvratt, Roy G. Smith +4 more |
1998-05-26 |
$93,595,000 |
| 5284841 |
Benzo-fused lactams promote release of growth hormone |
Michael H. Fisher, Helmut Mrozik, William R. Schoen |
1994-02-08 |
$60,772,000 |
| 5262400 |
4.alpha.-substituted avermectin derivatives |
Helmut Mrozik, Todd K. Jones |
1993-11-16 |
$42,536,000 |
